BioSim?抗Pembrolizumab（Keytruda?）（人類）ELISA試劑盒-BioSim? anti-Pembrolizumab (Keytruda?) (Human) ELISA Kit代理/參數(shù)/廠家-細胞分析試劑盒-艾美捷科技有限公司

PRODUCT CENTER

細胞分析試劑盒

產(chǎn)品中心

當前位置：首頁 > 產(chǎn)品中心 > 細胞生物學產(chǎn)品 > 細胞分析試劑盒

購買方式: 銀行轉(zhuǎn)賬、電匯、支票、現(xiàn)金，在線支付寶及網(wǎng)銀支付，或直接與我們電話聯(lián)系400-6800-868.

產(chǎn)品描述: Pembrolizumab (Keytruda?) is an antibody drug that targets the cell surface receptor programmed cell death protein 1 (PD-1) found on T cells. By preventing the binding of its ligands (PD-L1 and PD-L2), pembrolizumab induces an antitumor immune response. Upregulation of PD-1 ligands is a mechanism for tumors to evade antitumor immune response; when PD-1 binds its ligand, the T cell receives an inhibitory signal leading to T cell anergy and blockade of anti-tumour immune response. Instead of directly targeting tumor tissue to induce tumor cell death, pembrolizumab acts as a checkpoint inhibitor to stimulate immune responses to eliminate cancer cells. However, some patients develop unwanted immunogenicity, which leads to production of anti-drug-antibodies (ADAs) inactivating the therapeutic effects of the treatment and, in rare cases, inducing adverse effects. BioVision’s BioSimTM anti-Pembrolizumab ELISA kit is designed to detect antibody against Pembrolizumab with high specificity and sensitivity in biological matrices.

產(chǎn)品特點: Easy, convenient, sensitive and time-saving method toqualitative determination of antibody against Pembrolizumab (Keytruda) in human serum and plasma. Cross Reactivity: Pembrolizumab (Keytruda

其他: BioVision的公司總部在美麗的舊金山灣地區(qū)，它是全球生命科學公司的領(lǐng)導者.BioVision在開發(fā)和研究細胞凋亡檢測分析、代謝檢測方面具有卓越的影響力.包括檢測各種檢測分析試劑盒、相關(guān)特色抗體、重組蛋白及細胞因子和酶等多種產(chǎn)品，以及其他創(chuàng)新的研究工具.其產(chǎn)品覆蓋細胞凋亡研究、能量代謝、細胞/組織蛋白提取、氧化應(yīng)激與損傷、代謝與肥胖癥、細胞增殖與毒性、信號轉(zhuǎn)導、干細胞研究等領(lǐng)域.作為多家知名品牌的中國總代理以及中國區(qū)域代理，艾美捷與BioVision一起為研究者們提供最好、最新的細胞生物學研究工具而不斷擴大產(chǎn)品及服務(wù)質(zhì)量.